|
Per the field clinical specialist, during a transcatheter aortic valve replacement (tavr) procedure using a 23 mm sapien 3 ultra valve, it appeared that the distal struts may have momentarily hung-up during deployment.The distal portion of the balloon began to inflate initially but seemed to catch, while the proximal portion continued to expand.Once balloon expansion progressed, the distal segment ultimately fully inflated.The post-deployment angiogram showed a well positioned valve with no paravalvular leak (pvl) and minimal gradient.There was no evidence of pvl.An 85/15 saline-to-contrast mixture was used.Moderate force was required to advance the commander delivery system through the sheath, as it appeared to encounter slight resistance before exiting the distal sheath into the ascending aorta.
|
|
Correction to h6; type of investigation, investigation findings, and investigation conclusion.Update to d9 and h3.The event reported is anticipated in the risk management documentation for transcatheter heart valve procedures.Additional assessment of the failure mode(s) is not required at this time.The device was returned for examination.A visual inspection of the returned device was performed, and no abnormalities were observed.Functional testing was conducted to evaluate balloon deployment and inflation/deflation time, and the results were found to be within specification.Due to the nature of the complaint event, no applicable dimensional testing was performed.Imaging evaluation demonstrated that the valve initially expanded on the outflow side, with the inflow side taking slightly longer to open.Both the inflow and outflow sides ultimately expanded, and the valve was successfully deployed.The instructions for use (ifu), and training manuals have been reviewed.No inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported event was confirmed based on review of imagery provided.Evaluation of the returned product showed that the device conforms to specifications.A review of the dhr, lot history, and complaint history did not provide any indication that a manufacturing non-conformance would have contributed to the complaint event.A review of the ifu/training materials revealed no deficiencies.Furthermore, no abnormalities were reported during device unpacking or preparation.As reported, "distal struts may have momentarily hung-up during deployment.The distal portion of the balloon began to inflate initially but seemed to catch, while the proximal portion continued to expand.Once balloon expansion progressed, the distal segment ultimately fully inflated.Moderate force was required to advance the commander delivery system through the sheath, as it appeared to encounter slight resistance before exiting the distal sheath into the ascending aorta." investigation results did not conclusively identify the root cause.The reported event may be related to patient anatomy such as annulus shape, valve morphology, and calcium distribution interacting with balloon deployment.However, 3mensio was not provided.Additionally, the asymmetrical deployment is similar to the constrained inflation as described in a previous investigation; however, there is insufficient evidence to confirm the event is related to sheath's distal tip separation.Furthermore, there was no reported damage to the sheath, and the sheath was not returned for evaluation.Based on the available information, the root cause remains indeterminable.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Since no edwards product defects or labeling deficiencies were identified, no corrective or preventative action is required.
|